Primary Advanced Unresectable Pancreatic Cancer
作者： Ralf Wilkowski , Maria Wolf , Volker Heinemann
DOI: 10.1007/978-3-540-71279-4_10
关键词:
摘要: Median as well overall survival of pancreatic cancer patients in the advanced stage is extremely low despite advances therapy regarding tumor cell biology, resistance, and diagnosis. In matters chemoradiation (CRT) locally cancer, favorable positive effect has been reached with different radiotherapy proceedings such intraoperative radiation or without external chemo-/radiation CRT alone regard to local pain, remission, control disease survival. Primary (chemo-) only rarely leads remission. Intraoperative (IORT) merely reaches pain palliation most cases. By administering up-to-date primary CRT, especially gemcitabine-associated remission up 50% can be observed.
springer.com
sci-hub.st 参考文章(110)
Stephan Mose, Martin Karapetian, Lotte Jüling-Pohlit, Brigitte Taborski, Ulla Ramm, Marc Damrau, Angelika Rahn, Heinz D. Böttcher, VerstÄrkung der radiotherapeutischen wirkung auf HeLa-Zellen durch gemcitabine Strahlentherapie und Onkologie. ,vol. 175, pp. 78- 83 ,(1999) , 10.1007/BF02753847
Robert A. Wolff, Paul Chiao, Renato Lenzi, Peter W.T. Pisters, Jeffrey E. Lee, Nora A. JanJan, Christopher H. Crane, Douglas B. Evans, James L. Abbruzzese, Current approaches and future strategies for pancreatic carcinoma. Investigational New Drugs. ,vol. 18, pp. 43- 56 ,(2000) , 10.1023/A:1006383831045
Sergio Pedrazzoli, Valerio DiCarlo, Renzo Dionigi, Franco Mosca, Paolo Pederzoli, Claudio Pasquali, Günter Klöppel, Karl Dhaene, Fabrizio Michelassi, Standard Versus Extended Lymphadenectomy Associated With Pancreatoduodenectomy in the Surgical Treatment of Adenocarcinoma of the Head of the Pancreas Annals of Surgery. ,vol. 228, pp. 508- 517 ,(1998) , 10.1097/00000658-199810000-00007
Nicholas Alexakis, Paula Ghaneh, John P. Neoptolemos, Epidemiology of Pancreatic Cancer Blackwell Publishing Ltd.. pp. 571- 582 ,(2007) , 10.1002/9781444300123.CH57
R. Wilkowski, V. Heinemann, C. Stoffregen, Gemcitabine (Gemzar) and radiotherapy--is it feasible? Frontiers of Radiation Therapy and Oncology. ,vol. 37, pp. 78- 83 ,(2002) , 10.1159/000061300
B. Chauffert, F. Mornex, F. Bonnetain, J. P. Triboulet, O. Bouche, P. Rougier, J. F. Bosset, T. Aparicio, F. Masskouri, L. Bedenne, Phase III trial comparing initial chemoradiotherapy (intermittent cisplatin and infusional 5-FU) followed by gemcitabine vs. gemcitabine alone in patients with locally advanced non metastatic pancreatic cancer: A FFCD-SFRO study Journal of Clinical Oncology. ,vol. 24, pp. 4008- 4008 ,(2006) , 10.1200/JCO.2006.24.18_SUPPL.4008
G V Kornek, A Schratter-Sehn, A Marczell, D Depisch, J Karner, G Krauss, K Haider, W Kwasny, G Locker, W Scheithauer, Treatment of unresectable, locally advanced pancreatic adenocarcinoma with combined radiochemotherapy with 5-fluorouracil, leucovorin and cisplatin. British Journal of Cancer. ,vol. 82, pp. 98- 103 ,(2000) , 10.1054/BJOC.1999.0884
J P Hoffman, S Lipsitz, T Pisansky, J L Weese, L Solin, A B Benson, Phase II trial of preoperative radiation therapy and chemotherapy for patients with localized, resectable adenocarcinoma of the pancreas: an Eastern Cooperative Oncology Group Study. Journal of Clinical Oncology. ,vol. 16, pp. 317- 323 ,(1998) , 10.1200/JCO.1998.16.1.317
D J Klaassen, J M MacIntyre, G E Catton, P F Engstrom, C G Moertel, Treatment of locally unresectable cancer of the stomach and pancreas: a randomized comparison of 5-fluorouracil alone with radiation plus concurrent and maintenance 5-fluorouracil--an Eastern Cooperative Oncology Group study. Journal of Clinical Oncology. ,vol. 3, pp. 373- 378 ,(1985) , 10.1200/JCO.1985.3.3.373
F R Spitz, J L Abbruzzese, J E Lee, P W Pisters, A M Lowy, C J Fenoglio, K R Cleary, N A Janjan, M S Goswitz, T A Rich, D B Evans, Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas. Journal of Clinical Oncology. ,vol. 15, pp. 928- 937 ,(1997) , 10.1200/JCO.1997.15.3.928